This inventor holds 2 USPTO granted patents. Top assignees: University of California, University of South Florida. Active years: 2017-2020.
Location History:
- Wesley Chapel, FL (US) (2017)
- Tampa, FL (US) (2020)
Company Filing History:
2 out of 15,977 
2 out of 1,984 
Years Active: 2017-2020
Title: The Innovations of Derek Nichols
Introduction
Derek Nichols is an accomplished inventor based in Tampa, FL (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of beta-lactamase inhibitors. With a total of 2 patents, his work has the potential to impact the treatment of various infections and diseases.
Latest Patents
Derek's latest patents focus on compositions, methods of use, and methods of treatment involving beta-lactamase inhibitors. These embodiments relate to pharmaceutical compositions that include a beta-lactamase inhibitor, as well as methods for treating conditions such as infections or diseases. His innovative approaches aim to enhance the effectiveness of treatments through these compositions.
Career Highlights
Throughout his career, Derek has worked with prestigious institutions such as the University of South Florida and the University of California. His experience in these academic environments has allowed him to collaborate with leading researchers and contribute to groundbreaking advancements in his field.
Collaborations
Derek has had the opportunity to work alongside talented individuals such as Yu Chen and Adam Renslo. These collaborations have enriched his research and fostered a dynamic exchange of ideas, further enhancing the impact of his inventions.
Conclusion
Derek Nichols exemplifies the spirit of innovation in the pharmaceutical industry. His work on beta-lactamase inhibitors showcases his commitment to improving treatment options for infections and diseases. Through his patents and collaborations, he continues to make strides in the field of medicine.